a Magnetic resonance imaging (MRI) contrast agents with both positive (T 1 ) and negative (T 2 ) contrast abilities are needed in clinical diagnosis for fault-free accurate detection of lesions. We report a facile synthesis of europium-engineered iron oxide (EuIO) nanocubes as T 1 and T 2 contrast agents for MRI in living subjects. The Eu(III) oxide-embedded iron oxide nanoparticles significantly increase the T 1 relaxivity with an enhanced positive contrast effect. EuIO nanocubes with 14 nm in diameter showed a high r 1 value of 36.8 mM −1 s −1 with respect to total metal ions (Fe + Eu), which is about 3 times higher than that of Fe 3 O 4 nanoparticles with similar size. Moreover, both r 1 and r 2 values of EuIO nanocubes can be tuned by varying their sizes and Eu doping ratios. After citrate coating, EuIO nanocubes can provide enhanced T 1 and T 2 contrast effects in small animals, particularly in the cardiac and liver regions. This work may provide an insightful strategy to design MRI contrast agents with both positive and negative contrast abilities for biomedical applications.
Introduction
Magnetic resonance imaging (MRI) has been widely used in the clinic owing to the noninvasive character and high spatial resolution in soft issue. [1] [2] [3] Magnetic nanomaterials are employed as contrast agents to improve the sensitivity and reliability of MRI by accelerating the proton relaxation of the nearby water molecules. 4, 5 As a result, they are able to enhance the contrast of the region of interest from the background under external magnetic fields. There are two types of contrast agents, T 1 positive contrast agents (e.g., Gd chelates, paramagnetic Gd 2 O 3 and MnO nanomaterials), [6] [7] [8] [9] and T 2 negative contrast agents (e.g., superparamagnetic Fe 3 O 4 , ZnFe 2 O 4 and Fe 5 C 2 nanomaterials). [10] [11] [12] [13] [14] [15] However, these single modal MRI contrast agents have high risk of pseudo-positive signals in diagnosing lesions due to the intrinsic background from tissues in their vicinity. For example, T 1 -weighted MRI with bright signals may confuse with neighboring adipose tissues, whereas T 2 -weighted MRI showing darker signals is not favorable for distinguishing tissues in some occasions. 16, 17 Therefore, MRI contrast agents with both positive (T 1 ) and negative (T 2 ) contrast abilities are needed in clinical diagnosis for faultfree accurate detection of diseases. Ultrasmall iron oxide (IO) nanoparticles can display T 1 -T 2 dual-modal MRI behavior because of strong surface spin-canting effect and low magnetization. 18, 19 However, they usually show low relaxivities and worse still low stability in biological media, 20 which hinders the further applications as efficient T 1 -and T 2 -weighted MRI contrast agents. Paramagnetic metals (e.g., Mn 2+ ) promise highly efficient T 1 contrast due to the presence of unpaired electrons. [21] [22] [23] The doping of paramagnetic metals into iron oxide nanoparticles can achieve enhanced T 1 contrast and even tunable T 1 -T 2 dual-modal contrasts in contrast-enhanced MRI applications. 24, 25 There are also other strategies to construct dual modal MR imaging, such as combining T 1 and T 2 contrast agents together via hybrid heterostructures and designing a "magnetically decoupled" core-shell structure. 26, 27 On the other hand, lanthanide (Ln) ions, such as Gd 3+ with seven unpaired electrons, were employed to enhance the contrast abilities of iron oxide nanoparticles through the embedding strategy, which promises enhanced T 1 and T 2 contrast efficiency for sensitive and accurate MR imaging and disease diagnosis. [28] [29] [30] [31] [32] 
Experimental section

Preparation of metal-oleate complex
A metal-oleate complex was prepared by reacting sodium oleate and metal chlorides following a typical modified method from the literature. 33 Briefly, 0.811 g of ferric chloride (5 mmol) and 4.567 g of sodium oleate (15 mmol) were dissolved in the solvent mixed with 20 mL ethanol, 15 mL distilled water and 30 mL hexane. The resulting mixture was heated to 70°C and stirred for four hours. After cooling to room temperature, the upper layer containing iron-oleate was washed with distilled water three times. The resulting redbrownish iron-oleate complex in a waxy solid form was obtained after evaporating hexane. The europium-oleate complex (white powder) was produced in a similar way but using europium chlorides as precursors.
Preparation of monodispersed EuIO nanocubes
Monodispersed hydrophobic EuIO nanocubes were synthesized by thermal decomposition of metal-oleate complexes. as the solvent. After reflux for 1.5 hours under a nitrogen atmosphere and cooling to room temperature, the nanoparticles were precipitated with isopropanol, then washed with ethanol, separated by centrifugation and redispersed in hexane for further use. For 14 nm monodispersed Eu 2 O 3 nanoparticles, europium oleate (0.996 g, 1 mmol) was dissolved in trioctylamine (10 mL) containing oleic acid (0.16 mL), the reaction was heated to reflux temperature and maintained for one hour. After cooling to room temperature, ethanol was added to precipitate the nanoparticles, and then the product was washed with ethanol and redispersed in hexane for further use.
Preparation of sodium citrate coated EuIO nanocubes
We choose sodium citrate as a phase transfer agent because it gives a much smaller hydrodynamic radius than polymeric ligands. 4 mL of EuIO nanocube hexane solution (containing 10 mg nanocubes) was mixed with 4 mL of distilled water including 60 mg of sodium citrate, the mixture was added to 6 mL acetone and heated at 70°C for four hours. The products were collected by centrifugation after being cooled to room temperature. The EuIO nanocubes were then purified using sterilized membrane filters ( pore size of 0.22 μm) for further use. The Fe 3 O 4 and Eu 2 O 3 nanoparticles were also coated with sodium citrate using similar methods.
Cytotoxicity assay
The cytotoxicity of the EuIO nanocubes (sodium citrate coating) was tested by the 3- The OD 492 value (Abs.) of each well was measured using a MultiSkan FC microplate reader immediately. Cell viability was calculated from the OD 492 value of the experimental group by subtracting that of the blank group.
Cell uptake study
The SMMC-7721 cells (1 × 10 6 ) were seeded in the dish for 12 h, after washing cells twice with PBS, we added 10 mL RPMI-1640 containing EuIO nanocubes and Fe 3 O 4 nanoparticles with different concentrations (0.8, 0.4 and 0.2 mM of total metals, respectively) and incubated at 37°C for 5 h. The cells were harvested and washed with PBS buffer three times to remove the free nanoparticles. Then we collected the cells in a 0.6 mL graduated centrifuge tube by centrifugation for MRI scanning. The MRI experiment was performed on a 0.5 T MRI scanner.
Relaxivity and MRI phantom studies at 0.5 T All experiments were performed on a 0.5 T NMI20-Analyst NMR system (Niumag Corporation, Shanghai, China 
In vivo MRI study
All the samples were filtered through sterilized membrane filters ( pore size 0.22 μm) for further use. Healthy SpragueDawley rats weighing about 180-220 g were chosen for in vivo MRI studies. T 1 -weighted MR images of the heart and T 2 -weighted MR images of the liver were obtained on a Philips (Achieva 3.0 T) MRI scanner. The rats (for each group, n = 3) were intravenously injected 14 nm sized EuIO nanocubes with a dose of 2 mg (Eu + Fe) per kg of body weight. For T 1 imaging, time-scale acquisition of images was acquired at different time points (1 min, 3 min and 5 min) post-injection with the same slices. The images were obtained using a 3D CEMRA (contrast enhanced angiography) sequence under the following parameters: TR/TE = 7/3 ms, thickness = 1 mm, 1024 × 1024 matrices, FOV = 100 × 100 mm, flip angle = 30°. For T 2 imaging, the slices were further acquired at different time points (30 min, 90 min and 150 min) after the injection. The images were obtained using a fast spin-echo sequence (TSE) under the following parameters: TR/TE = 2000/66 ms, thickness = 1 mm, 144 × 144 matrices, FOV = 50 × 50 mm, flip angle = 90°. To quantify the contrast enhancement, the signal-tonoise ratio (SNR) was measured by analyzing regions of interest (ROIs) of the images, and the contrast enhancement was defined as the decrease of SNR after the injection, ΔSNR = (|SNR post − SNR pre |)/SNR pre .
Characterization
Transmission electron microscopy (TEM) and high-resolution TEM (HRTEM) images were obtained by using a JEM-2100 microscope with an accelerating voltage of 200 kV. The X-ray diffraction (XRD) patterns were acquired on a Rigaku Ultima IV system. The energy-dispersive X-ray (EDX) element mapping analysis was performed on a Tecnai F30 microscope at an accelerating voltage of 300 kV. The hysteresis loops (at 300 K) were recorded on a Quantum Design MPMS-XL-7 system. The samples ready for magnetization measurement were washed three times and then treated with plasma cleaning (PDC-32G, Harrick Plasma) to remove the surfactants. The metal concentration of the samples was detected by inductively coupled plasma atomic emission spectroscopy (ICP-AES). The dynamic light scattering (DLS) measurements were performed on a Malvern Zetasizer nano ZS instrument.
Statistical analysis
Statistical analysis was performed using the Student's t-test for unpaired data and the diameter of as-synthesized nanoparticles was calculated using Image J.
Results and discussion
We used iron oleate and europium oleate as precursors to prepare EuIO nanocubes in 1-octadecene solvent in the presence of oleic acid, which is different from the reported method of preparing europium doped iron oxide nanoparticles using ferric acetylacetonate and europium acetylacetonate as precursors. 34 We were able to tune the size of EuIO nanoparticles by varying the reaction time. The EuIO nanocubes with the sizes of 10, 14 and 20 nm in diameter were synthesized with reflux times of 1, 1.5 and 2 hours, respectively (Fig. 1a-c) . Transmission electron microscopy (TEM) images showed that they are of uniform cubic shape with narrow size distribution. After coating with sodium citrate, dynamic light scattering (DLS) analysis indicated that they are stable in water with hydrodynamic diameters of 10.0 ± 1.7, 14.0 ± 1.9, and 20.1 ± 2.4 nm, respectively ( Fig. 1d-f ). EuIO nanocubes with different Eu molar ratios (6.4%, 10.3% and 15.1%) were also prepared by tuning the proportions of the two precursors (ESI, Fig. S1 †) . High-resolution TEM (HRTEM) image of the 14 nm sized EuIO nanocubes (Fig. 2a, inset ) reveals a crossed lattice spacing distance of about 2.9 Å corresponding to (220) planes of the Fe 3 O 4 crystal. The energy-dispersive X-ray (EDX) line scanning analysis and element mapping indicate that Eu(III) ions are homogeneously distributed in iron oxide nanoparticles (Fig. 2d,e) . X-ray diffraction (XRD) patterns showed mixed diffraction peaks of inverse spinel structures of magnetite (JCPDS no. 00-003-0863) and hexagonal Eu 2 O 3 (JCPDS no. 00-019-0463) phases (Fig. 2b) . The selected area electron diffraction (SAED) of EuIO nanoparticles also exhibited a mixed crystalline nature (Fig. 2c) . These results are different from that of either the doped ferrites with inverse or normal spinel crystalline structures, 15, 35 indicating that EuIO nanocubes are composed of mixed magnetite and Eu 2 O 3 nanoclusters. This phenomenon is probably due to the fact that the large size of Eu(III) ions (94.7 pm in radius) is unable to occupy either the tetrahedral or the octahedral interstitial sites in the spinel structure. We also used synchrotron X-ray absorption spectroscopy (XAS) to further envision the structure of EuIO nanocubes, which allows for analyzing coordination geometry, bonding environment, and the electronic structure of central atoms. 36 The Fe K-edge XAS spectra of EuIO nanocubes are comparable to those of Fe 3 O 4 nanoparticles (Fig. 3a) , indicating that the inverse spinel structure of Fe 3 O 4 was unaltered after Eu 2 O 3 embedding. However, the peak intensity of the EuIO sample is lower than that of the Fe 3 O 4 nanoparticles, suggesting that the embedded Eu 2 O 3 nanoclusters may disturb the long range order of spins of iron oxide nanoparticles. The absorption peaks of the Eu L III -edge XAS spectrum of EuIO nanocubes (Fig. 3b) are attributed to the 2p 3/2 /5d electron transition for the trivalent Eu L III -edges, indicating typical Eu(III) characteristics.
37-39
Standard zero-field cooling (ZFC) and field cooling (FC) measurements for EuIO nanocubes (Fig. 4a) showed the estimated blocking temperature of about 180 K, which are lower than 220 K for magnetite nanoparticles (Fig. 4b) . The hysteresis loops (M-H) revealed that EuIO nanocubes are partially paramagnetic without magnetic hysteresis at 300 K, which is different from the superparamagnetic behaviors of magnetite nanoparticles (Fig. 4c,d, and insets) . This phenomenon is probably attributed to the enhanced spin canting effect on the surface layer of EuIO nanocubes after Eu 2 O 3 embedding due to the enhanced thermal agitation effect. 40 The inner location of Eu 2 O 3 clusters in iron oxide nanoparticles may disturb the local magnetic field intensity of the whole nanoparticle and finally reduce the saturated magnetization (M s ). Besides, the doping of Eu 2 O 3 with low magnetization may also decrease the total M s values of EuIO nanocubes. 41 As a result, the M s value of EuIO nanocubes (∼39.6 emu g −1 ) is lower than that of magnetite nanoparticles with a similar size (∼53.4 emu g −1 )
at 300 K. To evaluate the MR contrast ability of EuIO nanocubes, we firstly measured the relaxivities of citrate coated EuIO samples with different sizes and different Eu molar ratios. Larger EuIO nanoparticles have relatively higher M s values, which can be attributed to the loss of the predominant spin canting effect on the particle surface. [42] [43] [44] Nanoparticles with higher M s values may generate stronger local magnetic field inhomogeneities for the water proton dephasing process around the nanoparticles according to the quantum mechanical outer sphere theory. 45, 46 As a result, larger EuIO nanocubes have higher r 1 and r 2 values (Fig. S3 and Table S1 †). The Eu molar ratio also plays an important role in the r 1 and r 2 values of EuIO nanocubes, raising the Eu molar ratio increases r 1 values while reducing r 2 values (Fig. S4 †) . The decrease of r 2 values is probably due to the reduction of the M s values after Eu embedding. The increased r 1 value may be attributed to the spin order of Eu(III) which has the same orientation as the local magnetic field. 31 However, when the Eu molar ratio reached 15.1%, both r 1 and r 2 values are diminished, which may be ascribed to the structure of Fe 3 O 4 nanoparticles disturbed severely by a large amount of Eu 2 O 3 nanoclusters (Table S2 †) . We also prepared Fe 3 O 4 and Eu 2 O 3 nanoparticles with about 14 nm in diameter for comparison (Fig. S2 †) . EuIO nanocubes showed increased signals in T 1 -weighted MR images (Fig. 5a ) and reduced signals in T 2 -weighted MR images (Fig. 5b) (Fig. 5c and S5 †). The increased r 1 value is probably due to the spin order of Eu(III) which has the same direction as the local magnetic field induced by the superparamagnetic iron oxide domains. Besides, the chemical exchange of the surface Eu(III) ions with the nearby water protons may enhance T 1 shortening compared with iron ions. The r 2 of EuIO nanocubes was 97.52 ± 2.16 mM that EuIO nanocubes show both T 1 and T 2 contrast effects in vitro, indicating the potential of EuIO nanocubes as T 1 -T 2 dual-modal contrast agents. We then performed the animal experiments using healthy Sprague-Dawley rats as models for in vivo MRI studies. The T 1 -weighted MR images at 3 T were obtained sequentially before and after intravenous injection of EuIO nanocubes with a dose of 2 mg [Fe + Eu] per kg of body weight (Fig. 7a) . The heart exhibited a significantly brighter signal at 1 min time point post-injection ( p.i.) and the ΔSNR was approximately 62.2% ( Fig. 7b and Table S5 †), which indicates a great potential of EuIO nanocubes as excellent T 1 contrast agents in vivo. Because nanoparticles are highly accumulated in the hepatic Kupffer cells of the liver due to the mononuclear phagocyte system (MPS), 49, 50 we then focused on the liver as the region of interest (ROI). The T 2 -weighted MR images at a 3 T MR scanner showed prominent T 2 contrast in the rat liver region after intravenous injection of EuIO nanoparticles with a dose of 2.0 mg [Fe + Eu] per kg of body weight (Fig. 8) . The analysis of MR signal changes in the liver region indicated that the maximal ΔSNR is about 77.3% at 90 min p.i. at 3 T (Fig. 8b and Table S6 †) . This result suggests that EuIO nanocubes have robust contrast effects for liver imaging with a diagnostic time window in two hours after intravenous administration, indicating a relatively long blood circulation time. 51 The animal experiments demonstrate that EuIO nanoparticles are able to show both T 1 and T 2 MRI contrast effects for an in vivo study, which may provide more useful information for diagnosis with enhanced accuracy.
Conclusions
In summary, we have demonstrated that EuIO nanocubes showed both T 1 and T 2 contrast enhancement effects in vitro and in vivo. Moreover, we can tune T 1 and T 2 contrast abilities by varying their sizes and Eu doping ratios, which is helpful to better understand the effects of size and doping on r 1 and r 2 values and rationally design T 1 -T 2 dual-modal MRI contrast agents. The synthesis of EuIO nanocubes is facile, highly reproducible, and convenient to scale up. The sodium citrate coated EuIO nanocubes displayed good biocompatibility and a relative long blood circulation time. These desirable characters render them as a promising candidate for T 1 -and T 2 -weighted contrast-enhanced MRI, which may provide a feasible strategy for accurate detection of lesions in future. The EuIO nanocubes may also bind with other biomolecules (e.g., antibody and peptides), thereby providing a versatile platform for targeting and self-confirmed imaging for biomedical applications. 
